Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AgfiledCriticalNovartis Ag
Priority to MYPI0401893priorityCriticalpatent/MY127600A/en
Publication of MY127600ApublicationCriticalpatent/MY127600A/en
THE PRESENT INVENTION IS CONCERNED WITH SOLID ORAL DOSAGE FORMS OF COMPRISING (A) AN ACTIVE AGENT SELECTED FROM VALSARTAN AND OPTIONALLY HCTZ, AND (B) PHARMACEUTICALLY ACCEPTABLE ADDITIVES SUITABLE FOR THE PREPARATION OF SOLID ORAL DOSAGE FORMS BY COMPRESSION METHODS.
MYPI04018931997-06-141997-06-14Solid oral dosage forms of valsartan
MY127600A
(en)
APPLICATION OF AT-1 RECEPTOR ANTAGONIST OR AT-2 RECEPTOR MODULATOR FOR TREATMENT OF DISEASES ASSOCIATED WITH INCREASING THE CONTENT OF AT-1 OR AT-2 RECEPTORS